APA (7th ed.) Citation

Kwilas, A. R., Ardiani, A., Donahue, R. N., Aftab, D. T., & Hodge, J. W. (2014). Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine. Journal of translational medicine, 12(1), 294. https://doi.org/10.1186/s12967-014-0294-y

Chicago Style (17th ed.) Citation

Kwilas, Anna R., Andressa Ardiani, Renee N. Donahue, Dana T. Aftab, and James W. Hodge. "Dual Effects of a Targeted Small-molecule Inhibitor (cabozantinib) on Immune-mediated Killing of Tumor Cells and Immune Tumor Microenvironment Permissiveness When Combined with a Cancer Vaccine." Journal of Translational Medicine 12, no. 1 (2014): 294. https://doi.org/10.1186/s12967-014-0294-y.

MLA (9th ed.) Citation

Kwilas, Anna R., et al. "Dual Effects of a Targeted Small-molecule Inhibitor (cabozantinib) on Immune-mediated Killing of Tumor Cells and Immune Tumor Microenvironment Permissiveness When Combined with a Cancer Vaccine." Journal of Translational Medicine, vol. 12, no. 1, 2014, p. 294, https://doi.org/10.1186/s12967-014-0294-y.